LASE

LASE looks like a story stock built on acquisitions rather than a viable business. FY2025 revenue jumped 144% to $8.34M, but that growth is almost entirely bought, not earned: the CMS (Oct 2024) and Beamer (2025) acquisitions are explicitly credited in the MD&A for 'enhanc[ing] our revenue mix,' while gross profit is just $1.20M — a 14.4% gross margin that is dismal for a company that brands itself a 'vertically integrated' photonics manufacturer claiming it can 'offer better prices' and 'control quality.' The economics underneath the top line are broken: operating income of -$13.3M (-159% operating margin) and net income of -$17.5M (-209% net margin) mean the company loses roughly two dollars for every dollar of product it sells.

The balance sheet is the disqualifier. Stockholders' equity is negative (-$5.04M) — the company is book-insolvent — and total liabilities of $14.5M more than doubled YoY while total assets shrank 45% to $9.45M. Current liabilities of $10.3M (up 302%) tower over $2.99M of current assets, a current ratio near 0.29, against just $650K of cash. With operating cash flow of -$6.39M, that cash covers barely a month of burn, so further dilution or distressed financing is all but certain — and shares already ballooned 128% to 32.6M in a single year. The accumulated deficit of -$25.2M and -$1.02 diluted EPS confirm this is a structural cash-incinerator, not a one-off stumble. Note the data quality caveat: the narrative is tagged as a 10-K yet capex/buyback/dividend figures only resolve to FY2023, so working-capital detail is thin — which only deepens the risk.